Orchestra BioMed (OBIO) Competitors $2.55 -0.08 (-3.04%) Closing price 04:00 PM EasternExtended Trading$2.64 +0.09 (+3.53%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OBIO vs. TMCI, DCTH, BFLY, SNWV, RXST, CLPT, DRTS, NPCE, SKIN, and TCMDShould you be buying Orchestra BioMed stock or one of its competitors? The main competitors of Orchestra BioMed include Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Butterfly Network (BFLY), Sanuwave Health (SNWV), RxSight (RXST), ClearPoint Neuro (CLPT), Alpha Tau Medical (DRTS), NeuroPace (NPCE), Beauty Health (SKIN), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. Orchestra BioMed vs. Its Competitors Treace Medical Concepts Delcath Systems Butterfly Network Sanuwave Health RxSight ClearPoint Neuro Alpha Tau Medical NeuroPace Beauty Health Tactile Systems Technology Orchestra BioMed (NASDAQ:OBIO) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment. Does the media prefer OBIO or TMCI? In the previous week, Orchestra BioMed had 9 more articles in the media than Treace Medical Concepts. MarketBeat recorded 10 mentions for Orchestra BioMed and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.95 beat Orchestra BioMed's score of 0.25 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orchestra BioMed 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in OBIO or TMCI? 53.2% of Orchestra BioMed shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 8.1% of Orchestra BioMed shares are owned by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate OBIO or TMCI? Orchestra BioMed currently has a consensus target price of $14.00, indicating a potential upside of 449.02%. Treace Medical Concepts has a consensus target price of $9.83, indicating a potential upside of 36.76%. Given Orchestra BioMed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Orchestra BioMed is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orchestra BioMed 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk and volatility, OBIO or TMCI? Orchestra BioMed has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Which has stronger earnings and valuation, OBIO or TMCI? Treace Medical Concepts has higher revenue and earnings than Orchestra BioMed. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Orchestra BioMed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrchestra BioMed$2.64M37.32-$61.02M-$1.83-1.39Treace Medical Concepts$209.36M2.17-$55.74M-$0.79-9.10 Is OBIO or TMCI more profitable? Treace Medical Concepts has a net margin of -23.01% compared to Orchestra BioMed's net margin of -2,367.49%. Treace Medical Concepts' return on equity of -46.76% beat Orchestra BioMed's return on equity.Company Net Margins Return on Equity Return on Assets Orchestra BioMed-2,367.49% -289.42% -110.04% Treace Medical Concepts -23.01%-46.76%-23.35% SummaryTreace Medical Concepts beats Orchestra BioMed on 10 of the 17 factors compared between the two stocks. Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBIO vs. The Competition Export to ExcelMetricOrchestra BioMedMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.53M$3.07B$5.76B$9.65BDividend YieldN/A2.22%3.91%4.09%P/E Ratio-1.3920.4830.7825.12Price / Sales37.32355.18456.64116.46Price / CashN/A41.5625.2228.45Price / Book2.939.549.375.95Net Income-$61.02M-$54.74M$3.26B$265.46M7 Day Performance-6.25%2.39%1.88%0.96%1 Month Performance-17.48%4.60%3.73%2.47%1 Year Performance-60.09%9.17%28.93%20.24% Orchestra BioMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOOrchestra BioMed3.397 of 5 stars$2.55-3.0%$14.00+449.0%-59.0%$98.53M$2.64M-1.394Earnings ReportAnalyst RevisionTMCITreace Medical Concepts2.6107 of 5 stars$6.57+2.8%$9.83+49.7%+13.9%$415.60M$209.36M-8.33250DCTHDelcath Systems2.638 of 5 stars$10.65+1.3%$24.50+130.2%+42.0%$372.36M$37.21M212.9060Short Interest ↑BFLYButterfly Network3.0434 of 5 stars$1.40+2.6%$3.00+115.1%+50.8%$351.18M$82.06M-4.98460News CoverageSNWVSanuwave Health2.5192 of 5 stars$40.42-5.4%$49.00+21.2%N/A$346.40M$32.63M-4.9040Positive NewsGap DownRXSTRxSight1.5058 of 5 stars$7.34+10.4%$10.00+36.2%-83.9%$303.01M$139.93M-9.26220Trending NewsShort Interest ↑CLPTClearPoint Neuro1.7003 of 5 stars$10.68+0.8%$19.67+84.1%+4.4%$299.49M$31.39M-14.08110Earnings ReportDRTSAlpha Tau Medical2.5543 of 5 stars$3.52-1.3%$8.00+127.6%+49.5%$298.14MN/A-7.6480NPCENeuroPace3.2721 of 5 stars$8.96+0.8%$17.00+89.7%+22.6%$292.41M$79.91M-10.61170News CoverageEarnings ReportShort Interest ↑Analyst RevisionSKINBeauty Health1.0941 of 5 stars$2.23+0.9%$2.63+17.8%+55.3%$282.85M$334.30M-8.021,030TCMDTactile Systems Technology2.4606 of 5 stars$12.69+4.3%$13.50+6.4%-3.2%$282.55M$292.98M20.451,037 Related Companies and Tools Related Companies TMCI Competitors DCTH Competitors BFLY Competitors SNWV Competitors RXST Competitors CLPT Competitors DRTS Competitors NPCE Competitors SKIN Competitors TCMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OBIO) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access